Connect your AI

Innoviva, Inc. INVA Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Merck & Co.MRK

$157M+726%

InsmedINSM

$30.31M+2.1%

SavaraSVRA

$45K-72.7%

ArriVent BioPharma, Inc.AVBP

$54.72M+740%

Ligand PharmaceuticalsLGND

$7.65M+81.3%

AlkermesALKS

$15.71M-46.8%

Other financials

Income statement

Revenue$98.0M+10.6%

Gross profit$75.8M+3.4%

Operating income$38.2M-7.9%

Net income$186.6M+501%

EPS (diluted)$2.22+400%

Balance sheet

Cash & equivalents$603.1M+89.0%

Total debt$269.4M-40.3%

Total equity$1.3B—

Total assets$1.8B+46.4%

Cash flow

Operating cash flow$35.3M-27.4%

CapEx$492.0K—

Free cash flow$34.8M-28.4%

Valuation

Market cap$1.74B+51.8%

Enterprise value$1.41B+9.7%

P/E3.5×—

P/S4.2×+1.0×

Profitability

Gross margin73.7%-9.9pp

Operating margin38.1%-11.2pp

Net margin119.9%+107pp

FCF margin54.1%+5.3pp

Returns & leverage

Return on equity29.1%—

Debt / equity0.2×—

Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Innoviva, Inc.'s stock issuance proceeds?: Innoviva, Inc. (INVA) reported stock issuance proceeds of $259K in Q1 2026.
How has Innoviva, Inc.'s stock issuance proceeds changed year-over-year?: Innoviva, Inc.'s stock issuance proceeds increased by 3.6% year-over-year, from $250K to $259K.
What is the long-term trend for Innoviva, Inc.'s stock issuance proceeds?: Over 4 years (2021 to 2025), Innoviva, Inc.'s stock issuance proceeds has grown at a 21.6% compound annual growth rate (CAGR), from $1.17M to $2.55M.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.